COMPANY NEWS
September 12, 2007
ANTICANCER, INC. RECEIVES PATENT FOR NEW TYPE OF AIDS DRUG
February 23, 2007
STEM CELLS FROM HAIR FOLLICLES MAY SOMEDAY REVERSE PARALYSIS
October 13, 2006
AXIS HOMOCYSTEINE PATENT IS GREATLY NARROWED BY EUROPEAN PATENT OFFICE OPPOSITION PROCEEDINGS ANNOUNCED BY A/C DIAGNOSTICS
April 7, 2005
OLYMPUS AND ANTICANCER INC. FORM TECHNOLOGY PARTNERSHIP FOR SMALL ANIMAL MOLECULAR IMAGING
September 1, 2004
RESPONSE TO ASCO ON CHEMOSENSITIVITY TESTING
July 8, 2004
ANTICANCER INC. RECEIVES SIXTH PATENT ON FLUORESCENCE IMAGING TECHNOLOGY
May 14, 2004
GENETIC PROFILE OF ANTICANCER'S MOUSE MODEL OF PROSTATE CANCER PREDICTS RECURRENCE IN HUMAN PROSTATE CANCER PATIENTS
July 16, 2003
A/C DIAGNOSTICS UNIT OF ANTICANCER, INC., RECEIVES FDA CLEARANCE FOR HOMOCYSTEINE TEST
June 30, 2003
NEW MULTI-MODALITY IMAGING TECHNOLOGY FOR CANCER DRUG DISCOVERY DEVELOPED BY ANTICANCER, INC. AND ROSWELL PARK CANCER INSTITUTE
November 4, 2002
ANTICANCER GIVES A LECTURE AT DANA-FARBER/HARVARD CANCER CENTER CANCER CELL BIOLOGY PROGRAM MINISIMPOSIUM ON MOLECULAR IMAGING
September 9, 2002
ANTICANCER PAPER High efficiency genetic modification of hair follicles and growing hair shafts IN PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA (DOI : /10.1073/pnas. 192453799)
September 1, 2002
ANTICANCER REVIEW PAPER Green fluorescent protein imaging of tumour growth, metastasis and angiogenesis in mouse models IN SEPTEMBER 2002 ISSUE OF LANCET ONCOLOGY
May 9, 2002
ANTICANCER’S IN VITRO DRUG RESPONSE ASSAY FOR INDIVIDUAL CANCER PATIENT TUMORS CORRELATES WITH SURVIVAL IN PATIENTS WITH HEAD AND NECK CANCER
May 7, 2002
ANTICANCER-COLD SPRING HARBOR LABORATORY COLLABORATIVE STUDY IN FEATURED ARTICLE A Senescence Program Contolled by p53 and p16INK4a Contribures to the Outcome of Cancer Therapy IN MAY 3 ISSUE OF CELL
May 6, 2002
ANTICANCER PUBLISHES PAPER WITH MEMORIAL SLOAN-KETTERING CANCER CENTER SHOWING ITS HDRA ASSAY FOR INDIVIDUALIZED PATIENT CHEMOTHERAPY SENSITIVITY CORRELATES WITH CANCER PATIENT SURVIVAL
April 26, 2002
ANTICANCER-COLD SPRING HARBOR LABORATORY COLLABORATIVE STUDY IN COVER STORY Dissecting p53 tumor suppressor functions in vivo IN APRIL ISSUE OF CANCER CELL
April 1, 2002
ANTICANCER REVIEW IN COVER STORY Green Fluorescent Protein Imaging of Tumor Cells in Mice ON APRIL 2002 ISSUE OF LAB ANIMAL
March 18, 2002
ANTICANCER PAPER IN COVER STORY Real-Time Optical Imaging of Primary Tumor Growth and Multiple Metastatic Events in a Pancreatic Cancer Orthotopic Model ON MARCH 1, 2002 ISSUE OF CANCER RESEARCH
March 14, 2002
ANTICANCER, INC., DEVELOPS TECHNOLOGY TO EXTERNALLY IMAGE SINGLE CANCER CELLS IN MICE
March 7, 2002
ANTICANCER INC PRESENTS LECTURE: "OPTICAL IMAGING WITH GREEN FLUORESCENT PROTEINS", AT UCLA'S CRUMP INSTITUTE FOR MOLECULAR IMAGING LECTURE SERIES.
August 7, 2001
ANTICANCER, INC., DEVELOPS NEW WHOLE-BODY IMAGING, INFECTIOUS-DESEASE MOUSE MODEL FOR NOVEL ANTIBIOTIC DISCOVERY
July 9, 2001
ANTICANCER, INC., RECEIVES FOUR PATENTS ON ITS FLUORESCENCE TUMOR IMAGING TECHNOLOGY
May 2001
ANTICANCER PAPER IN COVER STORY Visualization of GFP-Expressing Tumors and Metastasis In Vivo ON MAY, 2002 ISSUE OF BIOTECHNIQUES
February 26, 2001
ANTICANCER, INC., DEVELOPS WHOLE-BODY IMAGING OF TUMOR ANGIOGENESIS
Novemver 2000
ANTICANCER, INC NAMED SAN DIEGO BIOTECH COMPANY OF THE MONTH
October 24, 2000
ANTICANCER DEVELOPS REAL-TIME IN VIVO IMAGING OF GENE EXPRESSION
